| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/23/2003 | US20030017170 Methods for inhibiting tumor metastasis, and peptides useful therefor |
| 01/23/2003 | US20030017167 Colon tumor proteins,or immunogenic portions thereof; polynucleotides that encode such portions; antigen presenting cell that expresses a colon tumor protein; or a T cell that is specific for cells expressing such a protein. |
| 01/23/2003 | US20030017161 Polypeptides that are capable of modulating apoptosis; also Apo-2 chimeras, nucleic acid encoding Apo-2, and antibodies to Apo-2 |
| 01/23/2003 | US20030017160 Human checkpoint kinase, hCDS1, compositions and methods |
| 01/23/2003 | US20030017159 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| 01/23/2003 | US20030017157 Endothelial cell expression patterns |
| 01/23/2003 | US20030017156 Immunogenic polypeptide |
| 01/23/2003 | US20030017155 Treating a condition characterized by activation of the inflammatory cytokine cascade |
| 01/23/2003 | US20030017153 Determining whether a patient's immune system can be modified through stimulation of thymus function; sex steroids are ablated in the patient, and the resulting production of thymic factors is monitored. |
| 01/23/2003 | US20030017151 Receptor Activator of NF-kappa B antagonists; treatment of medical conditions that require the formation of new bone. |
| 01/23/2003 | US20030017150 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/23/2003 | US20030017147 Novel alpha-2-antiplasmin- binding molecules and treatment for pulmonary embolism, myocardial infarction, thrombosis or stroke in a patient |
| 01/23/2003 | US20030017146 Particularly an arginine decarboxylase that is a biosynthetic enzyme of E. Coli; treatment of cancer |
| 01/23/2003 | US20030017145 Treating subjects suffering from herpes virus infections, acquired immunodeficiency syndrome, and hepatitis C infections by administering a compound effective to inhibit the production or release of the ROMs. |
| 01/23/2003 | US20030017144 Lipase-containing composition and methods of use thereof |
| 01/23/2003 | US20030017141 Treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 01/23/2003 | US20030017140 Retroviral vector particles have a chimeric envelope protein consisting of an antigen binding site of an antibody or another peptide, fused to the envelope protein the retroviral vector. |
| 01/23/2003 | US20030017136 Pharmaceutical compositions comprising vitamin B12 and interferon-beta for treating multiple sclerosis |
| 01/23/2003 | US20030017135 Pharmaceutical compositions comprising vitamin B12 and interferon for treating multiple sclerosis |
| 01/23/2003 | US20030017121 Use of electrolytes (ions in solution) to suppress charging of inhalation aerosols |
| 01/23/2003 | CA2821544A1 Use of follistatin for the treatment of pulmonary fibrosis and fibrosis associated with inflammatory bowel disease |
| 01/23/2003 | CA2707767A1 Biologically active peptides |
| 01/23/2003 | CA2454181A1 Use of corticotroph-derived glycoprotein hormone to induce lipolysis |
| 01/23/2003 | CA2454135A1 Gpcs as modifiers of the irrtk and p21 pathways and methods of use |
| 01/23/2003 | CA2453574A1 Transgenic plants expressing cobalamin binding proteins |
| 01/23/2003 | CA2453557A1 Keratin-based products and methods for their productions |
| 01/23/2003 | CA2453531A1 Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
| 01/23/2003 | CA2453515A1 Linear and cyclic melanocortin receptor-specific peptides |
| 01/23/2003 | CA2453470A1 Use of follistatin for the treatment of hepatic fibrogenesis |
| 01/23/2003 | CA2453453A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | CA2453452A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/23/2003 | CA2453406A1 Methods for reducing immunogenicity of polypeptides |
| 01/23/2003 | CA2453403A1 Methods of inhibiting amyloid toxicity |
| 01/23/2003 | CA2453384A1 Insert for the treatment of dry eye |
| 01/23/2003 | CA2453362A1 Oligonucleotide-containing pharmacological compositions and their use |
| 01/23/2003 | CA2453346A1 A hydroxamic acid thrombospondin peptide analog that inhibits aggrecanase activity |
| 01/23/2003 | CA2453309A1 Peptide for regulation of tissue plasminogen activator |
| 01/23/2003 | CA2453285A1 Use of cross-linked, covalently bound urokinase plasminogen activator (scupa)-urokinase plasminogen activator receptor (supar) complex as a fibrinolytic agent |
| 01/23/2003 | CA2453169A1 Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity |
| 01/23/2003 | CA2453161A1 Lymphatic endothelial cells materials and methods |
| 01/23/2003 | CA2453027A1 Cyclic peptides as potent and selective melanocortin-4 receptor agonists |
| 01/23/2003 | CA2452593A1 Triple polypeptide complexes |
| 01/23/2003 | CA2452582A1 G-csf conjugates |
| 01/23/2003 | CA2452517A1 Recombinant vsv for the treatment of tumor cells |
| 01/23/2003 | CA2452476A1 Mediating the effects of alcohol consumption by orally administering active dry yeast |
| 01/23/2003 | CA2452417A1 Compositions comprising the biologicially active peptide ysl |
| 01/23/2003 | CA2451670A1 Enteral formulations |
| 01/23/2003 | CA2451469A1 Use of antimicrobial peptides as preservatives in ophthalmic preparations including solutions emulsions and suspensions |
| 01/23/2003 | CA2449504A1 Bridged bicyclic serine protease inhibitors |
| 01/23/2003 | CA2449411A1 Human cytokine receptor |
| 01/23/2003 | CA2434303A1 Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 01/22/2003 | EP1277843A2 Novel human genes and gene expression products related to colon cancer |
| 01/22/2003 | EP1277838A1 Recombinant anti-tumor RNASE |
| 01/22/2003 | EP1277837A2 Epididymis-specific DNA sequences and their use |
| 01/22/2003 | EP1277836A1 Modulation of the IAPs and NAIP for the treatment of proliferative diseases |
| 01/22/2003 | EP1277833A2 Costal-2 homologue |
| 01/22/2003 | EP1277764A2 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/22/2003 | EP1277762A2 Low allergenic protein variants |
| 01/22/2003 | EP1277477A2 Treatment of neurodegenerative diseases and the effects of aging |
| 01/22/2003 | EP1277476A1 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator |
| 01/22/2003 | EP1277475A1 Bone-strengthening agents, food compositions for strengthening bone and feed compositions for strengthening bone |
| 01/22/2003 | EP1276902A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 01/22/2003 | EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 01/22/2003 | EP1276887A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 01/22/2003 | EP1276877A2 Agent for postoperative use after the removal of bone tumours |
| 01/22/2003 | EP1276875A2 16835, a human phospholipase c and uses thereof |
| 01/22/2003 | EP1276872A2 A thymus expressed human cytochrome p450 (p450tec) |
| 01/22/2003 | EP1276866A2 Novel compounds |
| 01/22/2003 | EP1276862A2 Heparanase ii, a human heparanase paralog |
| 01/22/2003 | EP1276856A1 Albumin fusion proteins |
| 01/22/2003 | EP1276853A1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 01/22/2003 | EP1276849A2 Albumin fusion proteins |
| 01/22/2003 | EP1276766A2 G protein-coupled receptors |
| 01/22/2003 | EP1276764A1 Human polynucleotides, polypeptides, and antibodies |
| 01/22/2003 | EP1276762A1 Porphyromonas gingivalis recombinant proteins and truncations |
| 01/22/2003 | EP1276760A2 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 01/22/2003 | EP1276759A2 Reductive alkylation process on glycopeptides |
| 01/22/2003 | EP1276758A2 A glycopeptide and preparation thereof |
| 01/22/2003 | EP1276755A1 Novel compounds |
| 01/22/2003 | EP1276754A2 Materials and methods relating to lipid metabolism |
| 01/22/2003 | EP1276750A1 Antisense modulation of zinc finger protein-217 expression |
| 01/22/2003 | EP1276713A1 Inhibition of angiogenesis and tumor growth |
| 01/22/2003 | EP1276506A2 Sustained release drug compositions |
| 01/22/2003 | EP1276505A1 Mixtures of triblock polyesterpolyethylene glycol copolymers |
| 01/22/2003 | EP1276498A1 Use of npy y1 receptor antagonists in the treatment of inflammatory conditions |
| 01/22/2003 | EP1276497A2 Mixture of defibrotide and g-csf and its use for activating haematopoietic progenitors |
| 01/22/2003 | EP1276496A2 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 01/22/2003 | EP1276495A1 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases |
| 01/22/2003 | EP1276494A1 A memory enhancing protein |
| 01/22/2003 | EP1276493A2 Cxcr4 agonist treatment of hematopoietic cells |
| 01/22/2003 | EP1276492A2 P43 antigen for the immunodiagnosis of canine ehrlichiosis and uses thereof |
| 01/22/2003 | EP1276491A1 Tamandarin and didemnin analogs and methods of making and using them |
| 01/22/2003 | EP1276475A2 Topical anesthetic/opioid formulations and uses thereof |
| 01/22/2003 | EP1276474A2 Formulations for use in inhaler devices |
| 01/22/2003 | EP1276473A2 Pharmaceutical formulations for dry powder inhalers |
| 01/22/2003 | EP1276472A2 Formulations for use in inhaler devices |
| 01/22/2003 | EP1276471A2 Membrane delivery system |
| 01/22/2003 | EP1276469A2 Taste masking coating composition |
| 01/22/2003 | EP1276468A1 Use of particulate vectors in immunomodulation |
| 01/22/2003 | EP1228090A4 Novel molecules and the card-related protein family and uses thereof |